Sargent Bickham Lagudis’s Boston Scientific BSX Stock Holding History

Sargent Bickham Lagudis’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$9.44K	Hold	204	–	–	﹤0.01%	736
2022 Q3	$8K	Sell	204 -79	-28%	-$3.17K	﹤0.01%	717
2022 Q2	$11K	Buy	283 +79	+39%	+$3.22K	﹤0.01%	677
2022 Q1	$9K	Hold	204	–	–	﹤0.01%	722
2021 Q4	$9K	Hold	204	–	–	﹤0.01%	721
2021 Q3	$9K	Hold	204	–	–	﹤0.01%	730
2021 Q2	$9K	Hold	204	–	–	﹤0.01%	722
2021 Q1	$8K	Hold	204	–	–	﹤0.01%	731
2020 Q4	$7K	Sell	204 -144	-41%	-$5.19K	﹤0.01%	694
2020 Q3	$13K	Hold	348	–	–	﹤0.01%	558
2020 Q2	$12K	Sell	348 -871	-71%	-$31.4K	﹤0.01%	548
2020 Q1	$40K	Buy	1,219 +144	+13%	+$5.63K	0.01%	371
2019 Q4	$49K	Buy	+1,075	New	+$45K	0.01%	387
2019 Q2	–	Sell	-700	Closed	-$27K	–	757
2019 Q1	$27K	Hold	700	–	–	﹤0.01%	469
2018 Q4	$25K	Sell	700 -321	-31%	-$11.6K	﹤0.01%	457
2018 Q3	$39K	Buy	+1,021	New	+$35.7K	﹤0.01%	404
2018 Q1	–	Sell	-398	Closed	-$10K	–	760
2017 Q4	$10K	Buy	398 +255	+178%	+$7.03K	﹤0.01%	602
2017 Q3	$4K	Hold	143	–	–	﹤0.01%	704
2017 Q2	$4K	Buy	+143	New	+$3.79K	﹤0.01%	663

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Sargent Bickham Lagudis's BSX Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Boston Scientific (BSX) position steady in Q4 2022 at 204 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Sargent Bickham Lagudis first reported a position in BSX in Q2 2017 and has held it in 19 quarters since. The position peaked at $49K in Q4 2019. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Sargent Bickham Lagudis held 204 shares of Boston Scientific worth $9.44K as of Q4 2022.
Sargent Bickham Lagudis left its Boston Scientific share count unchanged in Q4 2022.
Boston Scientific made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #736 holding.
Sargent Bickham Lagudis first reported a position in Boston Scientific in Q2 2017 and has held it in 19 quarters since.
Sargent Bickham Lagudis's Boston Scientific position peaked at $49K in Q4 2019.
928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.